On Friday, October 16, Andrej Studen, a member of the Medical Physics research group, took part in the debate at the 3rd session of the subcommittee for cancer monitoring in Slovenia. The session was intended to examine the adequacy of the placement of proton therapy in Slovenia.
Andrej explained the group’s participation in research in the field of cancer treatment, from preventive work within the DORA program to monitoring the success of immunotherapy treatment. He emphasized that the research group was already involved in the development of the next generation of proton therapy within the RAPTOR research project, funded by the European Commission. He thinks that proton therapy complements the set of therapeutic and diagnostic methods with which we can help the patient to adapt to optimal treatment.
Link (35:20 to 39:10.):